Vanda Pharmaceuticals Inc.
NASDAQ:VNDABiotechnology
Healthcare
$3.81 -3.27%
-$0.20 today
- Market cap
- $230.39M
- Beta
- 0.60
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$4.03
52W Low $4.14High $9.94
Volume 0.83M
Average 1.29M
Price history
Vanda Pharmaceuticals Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-28.79%
Period high
$9.56
Period low
$3.59
Latest
$3.81
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Oct 29, 2026 | Oct 29, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| SC 13G/A | Oct 9, 2026 | Oct 9, 2026 | |
| SC 13G | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Jun 8, 2026 | Jun 8, 2026 | |
| 4 | Jun 8, 2026 | Jun 8, 2026 | |
| 4 | Jun 8, 2026 | Jun 8, 2026 | |
| 4 | Jun 8, 2026 | Jun 8, 2026 |
Competitors
Who does Vanda Pharmaceuticals Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about VNDA's filings, answered from its disclosures.
What is the latest VNDA filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does VNDA have?
Intrinsic Alpha currently shows 20 recent filings for VNDA.
Continue the stock analysis
Jump to another research area for this company.